Friday, July 31, 2026

AstraZeneca’s Elecoglipron: Can This New Weight Loss Pill Compete with GLP-1 Giants?

AstraZeneca's new weight-loss pill, elecoglipron, shows promising results in trials, competing with existing obesity treatments.

Ukrainian Intelligence Chief Warns of North Korean Troops’ Rapid Adaptation in Ukraine

North Korean forces are adapting to modern warfare, impacting Pacific security, as they assist Russia in Ukraine and receive training.

Tesla, Rivian, Nikola—EV Stocks Surge as Nvidia’s Rally Boosts Market

The Nasdaq jumped over 2% thanks to Nvidia's rally, U.S. stock markets surged, and electric vehicle stocks saw broad gains.

Tag: Cureverse Inc.

Revolutionizing Drug Development: Ewha Womans University Partners with Cureverse for AI-Powered Innovations

Ewha Womans University and Cureverse Inc. partner for AI-driven drug development, focusing on collaboration and expert training.

Top News

- Our Sponsors Ad -

Follow us